
Adaptimmune Therapeutics PLC
ADAPYOTCCIK 1621227HealthcareFiscal year ends Dec 31
Reports and events: 279 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-11-0816:05 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001558370-23-018265 |
| 2023-11-0807:37 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-23-018123 |
| 2023-11-0316:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001558370-23-017596 |
| 2023-10-3108:07 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-23-017061 |
| 2023-08-3117:19 ET | 8-K | 3.01 Delisting notice | 0001558370-23-015390 |
| 2023-08-1016:05 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001558370-23-014493 |
| 2023-08-0916:06 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001558370-23-014250 |
| 2023-08-0907:42 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-23-014085 |
| 2023-06-2916:25 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-23-076342 |
| 2023-06-0116:09 ET | 8-K | 2.01 Completion of an acquisition or disposition; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-067030 |
| 2023-05-3016:18 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-23-066048 |
| 2023-05-2206:59 ET | 8-K | 8.01 Other events | 0001104659-23-062908 |
| 2023-05-1607:35 ET | 8-K | 5.07 Shareholder vote results | 0001104659-23-061177 |
| 2023-05-1216:05 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001558370-23-009595 |
| 2023-05-1207:36 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-23-009504 |
| 2023-04-1308:00 ET | DEF 14A | Proxy statement | 0001104659-23-044825 |
| 2023-04-1108:08 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-23-005713 |
| 2023-03-3017:13 ET | SC 13D/A | Ownership report, active investor, amended | 0001072613-23-000276 |
| 2023-03-1016:54 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-23-003489 |
| 2023-03-0616:07 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001558370-23-002907 |
| 2023-03-0606:47 ET | 8-K | 1.02 Termination of a material agreement; 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001558370-23-002829 |
| 2023-03-0606:34 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-028734 |
| 2023-02-1608:14 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-23-001414 |
| 2023-01-3116:15 ET | 8-K | 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001558370-23-000722 |
| 2022-12-2016:05 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001558370-22-018828 |
| 2022-11-0816:14 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001558370-22-016869 |
| 2022-11-0807:42 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-22-016748 |
| 2022-11-0807:40 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-22-016746 |
| 2022-10-2508:10 ET | 8-K | 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001558370-22-015279 |
| 2022-09-0907:14 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-22-014297 |
| 2022-08-0416:06 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001558370-22-012182 |
| 2022-08-0407:36 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-22-012058 |
| 2022-06-1516:10 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001558370-22-010042 |
| 2022-05-2506:42 ET | 8-K | 5.07 Shareholder vote results | 0001104659-22-064428 |
| 2022-05-0916:06 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001558370-22-007810 |
| 2022-05-0907:40 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-22-007708 |
| 2022-05-0408:20 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001558370-22-006948 |
| 2022-04-2108:00 ET | DEF 14A | Proxy statementPeriod 2022-05-25 | 0001104659-22-048084 |
| 2022-03-1408:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-22-003492 |
| 2022-03-1407:16 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001558370-22-003489 |
| 2022-01-2608:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-22-007650 |
| 2021-11-1206:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-21-015611 |
| 2021-11-0416:11 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001558370-21-014594 |
| 2021-11-0407:40 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-21-014450 |
| 2021-09-1307:08 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-21-012408 |
| 2021-09-0707:08 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-21-012236 |
| 2021-08-2016:31 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001558370-21-011988 |
| 2021-08-1316:33 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001558370-21-011688 |
| 2021-08-0916:20 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001558370-21-010980 |
| 2021-08-0916:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-21-010969 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. Listed shows no prices and gives no investment advice.